Add time:08/13/2019         Source:sciencedirect.com

SummaryThe discovery of new leads acting via novel modes of action in the treatment of the human immunodeficiency virus (HIV), the causative agent of AIDS, remains a challenge. Along this line we synthesized and evaluated a series of N-substituted 4-aminophthalimides which were designed according to the models of thalidomide, phenytoin (PHT) and ameltolide. From a series of 24 compounds only N-1-adamantyl-4-aminophthalimide was endowed with anti-HIV-1 and -HIV-2 activity in CEM cell cultures.

We also recommend Trading Suppliers and Manufacturers of N-PHENYLTETRAFLUOROPHTHALIMIDE (cas 116508-58-8). Pls Click Website Link as below: cas 116508-58-8 suppliers